- Home
- XTLB vs CREV Comparison
XTLB vs CREV Comparison
Compare XTLB & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- CREV
- Stock Information
- Founded
- XTLB 1993
- CREV 2007
- Country
- XTLB Israel
- CREV Ireland
- Employees
- XTLB N/A
- CREV N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- CREV
- Sector
- XTLB Health Care
- CREV
- Exchange
- XTLB Nasdaq
- CREV Nasdaq
- Market Cap
- XTLB 10.8M
- CREV 8.8M
- IPO Year
- XTLB 2005
- CREV N/A
- Fundamental
- Price
- XTLB $2.17
- CREV $3.74
- Analyst Decision
- XTLB
- CREV Strong Buy
- Analyst Count
- XTLB 0
- CREV 1
- Target Price
- XTLB N/A
- CREV $39.00
- AVG Volume (30 Days)
- XTLB 5.9K
- CREV 38.1K
- Earning Date
- XTLB 11-20-2024
- CREV 01-01-0001
- Dividend Yield
- XTLB N/A
- CREV N/A
- EPS Growth
- XTLB N/A
- CREV N/A
- EPS
- XTLB N/A
- CREV N/A
- Revenue
- XTLB N/A
- CREV $39,261,077.00
- Revenue This Year
- XTLB N/A
- CREV $40.76
- Revenue Next Year
- XTLB N/A
- CREV $86.18
- P/E Ratio
- XTLB N/A
- CREV N/A
- Revenue Growth
- XTLB N/A
- CREV 41.52
- 52 Week Low
- XTLB $0.75
- CREV $3.51
- 52 Week High
- XTLB $4.99
- CREV $197.99
- Technical
- Relative Strength Index (RSI)
- XTLB 40.70
- CREV 32.65
- Support Level
- XTLB $1.97
- CREV $3.51
- Resistance Level
- XTLB $2.28
- CREV $4.77
- Average True Range (ATR)
- XTLB 0.13
- CREV 0.29
- MACD
- XTLB -0.02
- CREV -0.00
- Stochastic Oscillator
- XTLB 37.74
- CREV 16.43
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.